Literature DB >> 2901046

Precontraction-induced contractile response of isolated canine portal vein to alpha-2 adrenoceptor agonists.

T Furuta1.   

Abstract

The responses of isolated canine portal veins, in either transverse or longitudinal strip, to alpha-2 adrenoceptor agonists were examined. B-HT920, a selective alpha-2 adrenoceptor agonist, did not elicit an appreciable response in the transverse strips of the portal vein under resting tone (0.5 g/mm width). When the preparation was partially precontracted with phenylephrine, prostaglandin F2 alpha, KCl, Bay K 8644, acetylcholine, 5-hydroxytryptamine, histamine, or A23187, B-HT920 evoked concentration-dependent contractile responses (3 x 10(-9)-10(-6) M). Maximum contractions, which depended on the precontraction levels and the precontracting substances, ranged from 10-35% of those evoked by norepinephrine 10(-5) M. Similar precontraction-dependent contractile responses were obtained in the longitudinal strips. Concentration-response curves of B-HT920 in the transverse strips precontracted with prostaglandin F2 alpha were shifted by yohimbine to the right, but not by prazosin. Schild analysis yielded a slope of unity and a pA2 of 8.79. Clonidine also showed a similar precontraction-dependent contractile response. The lower part of the concentration-response curve of clonidine was shifted by yohimbine. These results may be explained by the presence of postsynaptic alpha-2 adrenoceptors in canine portal vein, which mediate a contractile response under certain conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901046     DOI: 10.1007/bf00182726

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  The regeneration of aortic endothelium.

Authors:  J C POOLE; A G SANDERS; H W FLOREY
Journal:  J Pathol Bacteriol       Date:  1958-01

2.  Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit.

Authors:  R Weitzell; T Tanaka; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

3.  Postsynaptic alpha adrenergic receptor subtypes differentiated by yohimbine in tissues from the rat. Existence of alpha-2 adrenergic receptors in rat aorta.

Authors:  R R Ruffolo; J E Waddell; E L Yaden
Journal:  J Pharmacol Exp Ther       Date:  1981-05       Impact factor: 4.030

Review 4.  alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs.

Authors:  P B Timmermans; P A van Zwieten
Journal:  J Med Chem       Date:  1982-12       Impact factor: 7.446

5.  Studies that question the existence of alpha-2 adrenoceptors in tail arteries of normotensive Sprague-Dawley rats.

Authors:  J F Marwood; K L Chapman; G S Stokes
Journal:  J Pharmacol Exp Ther       Date:  1986-07       Impact factor: 4.030

6.  Pharmacological characterization of the alpha adrenoceptors of the dog basilar artery.

Authors:  Y Sakakibara; M Fujiwara; I Muramatsu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

7.  Pharmacological characterization of the postsynaptic alpha adrenoceptors in vascular smooth muscle from canine and rat mesenteric vascular beds.

Authors:  D K Agrawal; C R Triggle; E E Daniel
Journal:  J Pharmacol Exp Ther       Date:  1984-06       Impact factor: 4.030

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  A regional difference in endothelium-dependent relaxation responses to acetylcholine in the canine venous system.

Authors:  T Furuta; T Shigei
Journal:  Jpn J Pharmacol       Date:  1987-06

10.  Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo.

Authors:  G M Drew; S B Whiting
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

View more
  8 in total

1.  The influence of the initial stretch and the agonist-induced tone on the effect of basal and stimulated release of EDRF.

Authors:  I A Dainty; J C McGrath; M Spedding; A G Templeton
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

Review 2.  Drugs and receptors. An overview of the current state of knowledge.

Authors:  T Kenakin
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

3.  Evidence for prazosin-resistant, rauwolscine-sensitive alpha-adrenoceptors mediating contractions in the isolated vascular bed of the rat tail.

Authors:  A G Templeton; J Macmillan; J C McGrath; N D Storey; V G Wilson
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

4.  Expression of functional postjunctional alpha 2-adrenoceptors in rabbit isolated distal saphenous artery--a permissive role for angiotensin II?

Authors:  W R Dunn; J C McGrath; V G Wilson
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

5.  Contraction-mediating alpha 2-adrenoceptors in the mouse vas deferens.

Authors:  R Bültmann; I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

6.  Postjunctional alpha-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional alpha 2-adrenoceptors.

Authors:  W R Dunn; J C McGrath; V G Wilson
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

7.  Effects of pre-contraction with endothelin-1 on alpha 2-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail.

Authors:  M R MacLean; J C McGrath
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

8.  Characterization of postsynaptic alpha-adrenoceptors in the arteries supplying the oviduct.

Authors:  G Costa; M Isla; A García-Pascual; E Jimenez; P Recio; A Labadia; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.